Navigation Links
PAREXEL International Reports Fourth Quarter and Fiscal Year 2011 Results
Date:8/9/2011

www.parexel.com">www.parexel.com.   Users should follow the instructions provided to assure that the necessary audio applications are downloaded and installed.  A replay of this webcast will be archived on the website approximately two hours after the call and will continue to be accessible for approximately one year following the live event.  To participate via telephone, dial +1 (408) 940-3886 and ask to join the PAREXEL quarterly conference call.

Certain trended financial information may be found in the Investor Relations section of the Company’s website under the “Additional Financials” section.  

About PAREXEL International PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has approximately 10,550 employees. For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL Internatio
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
2. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2011 Earnings Release and Conference Call
3. PAREXEL International to Present at Goldman Sachs Healthcare Conference and Jefferies Global Healthcare Conference
4. PAREXEL Invites Public to Listen to Live Webcast of Its Investor Day June 2, 2011
5. PAREXEL Reports Third Quarter Fiscal Year 2011 Financial Results
6. Key Presentations Announced for Landmark Future of Biosimilars Event Co-Sponsored by DIA and FDLI, Co-Chaired by Merck and PAREXEL
7. PAREXEL Expert Serves as Lead Author and Editor of Definitive Resource on Quality by Design (QbD), Aimed at Maximizing Product Quality and Speeding Treatments to Market
8. PAREXEL Announces Date of Third Quarter Fiscal Year 2011 Earnings Release and Conference Call
9. PAREXEL Experts To Address Best-Practice Strategic Partnership Models To Increase Operating Efficiency, Development Effectiveness at Partnerships in Clinical Trials
10. PAREXEL Experts to Present Advanced Approaches to Accelerate Development, Maximize Product Value at DIA EuroMeeting
11. PAREXEL International to Present at Raymond James Investors Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)...  The University of Maryland,s A. James Clark School ... the new A. James Clark Hall at the University ... transformative new engineering and biomedical technologies to accelerate advancements ... a.m. on November 21 at the site of the ... to the Jeong H. Kim Engineering Building, the event ...
(Date:11/21/2014)... SARASOTA, Fla. , Nov. 21, 2014   ... ) announced that the Company is scheduled to present ... San Francisco, CA on January 12-14, ... PhD, Chairman and CEO of Rock Creek Pharmaceuticals, will ... small molecule cholinergic agonist which exhibits anti-inflammatory pharmacological characteristics. ...
(Date:11/21/2014)... , Nov. 21, 2014  PTC Therapeutics, Inc. (NASDAQ: ... 2014 Legend of Technology Award for Vision, Innovation, and Leadership ... Chief Executive Officer. This award recognizes an individual who has ... New Jersey for several decades. ... Award," stated Stuart Peltz , Ph.D., CEO of PTC ...
Breaking Medicine Technology:University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 2Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 3Rock Creek Pharmaceuticals to Present at the Biotech Showcase 2015 4PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3
... Aug. 13 Mesa Laboratories, Inc. (Nasdaq: ... has declared a regular quarterly cash dividend of 11 ... 15, 2010 to shareholders of record at the close ... Laboratories develops, acquires, manufactures and markets electronic instruments and ...
... (Nasdaq: www.mylan.com . Forward-Looking Statements ... that constitute "forward-looking statements." These statements are made pursuant ... Litigation Reform Act of 1995. Because such statements inherently ... materially from those expressed or implied by such forward-looking ...
Cached Medicine Technology:
(Date:11/24/2014)... 2014 Olaparib functions as a chemical ... is one of the first PARP inhibitors. Sufferers with ... types of melanoma, and are often immune to other ... their malignancies a exclusive weaknesses, as the tissues of ... DNA and allow them to proceed splitting. This implies ...
(Date:11/24/2014)... November 24, 2014 Mental health ... day. They break up families, ruin careers, and ... hope for those that suffer,” says Hardy ... is showing that our specialized nutritional treatments can ... appear on “Mind Over Matter”, the premiere episode ...
(Date:11/24/2014)... 24, 2014 Gersowitz Libo & Korek, P.C., ... received national Tier recognition in the 2015 Edition of U.S. ... ranking signals a unique combination of quality law practice and ... receive this honor and especially grateful to our clients whose ... and ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled its ... They are now offered at deeply discounted prices, up to ... to Dec. 15. The main purpose of the promotion is ... quality items are ideal options for ladies who are eager ... All its new mint cocktail dresses are very beautiful; they ...
(Date:11/23/2014)... Pro Ace Care, a renowned Vancouver hot water tank ... an 8 year warranty on its selected hot water tanks. ... due to the impending winter season, it was important for ... service that the company provides. As a result, Pro Ace ... and Bradford hot water tanks. , “Every installer who ...
Breaking Medicine News(10 mins):Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 2Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 3Health News:Olaparib Industry (CAS 763113-22-0) 2009-2019 Global and China Research Reports is Now Available at RnRMarketResearch.com 4Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 2Health News:Nutritional Mental Health Treatment Featured on Access Health Airing on Lifetime Television® 3Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2
... primary biliary cirrhosis may lead to new treatments, researchers ... have found genetic variations that appear to increase the ... that can destroy the liver. , Primary biliary cirrhosis ... in the liver. It is a condition that mostly ...
... find similar results , WEDNESDAY, June 10 (HealthDay News) ... drugs after radiation therapy do better when the drug treatment ... six-month regimen, a European study has found. , The results ... in May, said Dr. Eric M. Horwitz, acting chairman of ...
... Geodon have been linked to certain health risks, experts note, ... and Drug Administration advisory panel on Wednesday voted ... approved to treat schizophrenia and bipolar disorder in children aged ... a decision on Geodon, a third antipsychotic in the ...
... Children,s National ... ... Imaging of critically ill children can now be done with minimal disruption and risk at ... of Potomac, Maryland, partnered with Children,s National to make imaging safer in the pediatric ...
... ThermoGenesis Corp. (Nasdaq: KOOL ), a leading supplier ... said today that J. Melville Engle, the Company,s Chief Executive ... appointment brings the total number of directors to six. , ... management experience in the healthcare industry, joined the Company as ...
... Trust for America,s Health (TFAH) today applauded the U.S. Senate ... strong prevention and public health components in the Affordable Health ... , "Our nation will never be able to contain ... keeping Americans healthier and preventing disease," said Jeff Levi, Ph.D., ...
Cached Medicine News:Health News:Genetic Links to Rare Liver Disease Found 2Health News:Genetic Links to Rare Liver Disease Found 3Health News:Longer Hormone Treatment May Improve Prostate Cancer Outlook 2Health News:Longer Hormone Treatment May Improve Prostate Cancer Outlook 3Health News:FDA Panel OKs Newer Antipsychotics for Children 2Health News:FDA Panel OKs Newer Antipsychotics for Children 3Health News:FDA Panel OKs Newer Antipsychotics for Children 4Health News:Imaging Is Now Easier for the Area's Vulnerable Children 2Health News:Imaging Is Now Easier for the Area's Vulnerable Children 3Health News:ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors 2Health News:ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors 3Health News:ThermoGenesis Appoints Chief Executive Officer J. Melville ('Mel') Engle to Board of Directors 4Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 2Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 3Health News:TFAH Applauds 'Affordable Health Choices Act' for Making Prevention a Cornerstone of Health Reform 4
... (IGF-I or somatomedin C) is a 7.6 kDa ... as a potent mitogen of cellular proliferation, exerting ... In the circulation, IGF-I is bound to IGF-binding ... of IGF-I by modulating the interaction of IGF-I ...
... (PSA) derives its name from its first ... The majority of PSA circulates bound ... Serum concentrations of PSA are elevated in ... (BPH) and prostatitis [1-3]. In addition, PSA ...
Inquire...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Medicine Products: